明胶凝血酶基质密封剂对青少年特发性脊柱侧凸后路脊柱融合术失血量的真实世界有效性:一项中断时间序列研究
该回顾性队列研究采用中断时间序列分析,纳入179例青少年特发性脊柱侧凸(AIS)后路脊柱融合术患者,比较明胶凝血酶基质密封剂(GTMS)引入前后失血量变化。结果显示GTMS引入与术中失血量减少340 mL(95%CI:-649至-31,P=0.03)及总失血量减少375 mL(95%CI:-698至-51,P=0.02)显著相关,而术后24小时引流量变化无显著差异。作者推荐在AIS手术中按需使用GTMS控制术中出血。
要点
- GTMS引入后术中失血量变化为-340 mL(95%CI:-649至-31,P=0.03)。
- GTMS引入后总失血量变化为-375 mL(95%CI:-698至-51,P=0.02)。
- 术后24小时引流量变化为-35 mL(95%CI:-124至55,P=0.44),无显著差异。
核心结论
- GTMS的可及性与AIS手术中术中失血量和总失血量的减少显著相关。
- 作者推荐在AIS手术中按需使用GTMS以控制术中出血。
研究设计与样本
- 回顾性队列研究,采用中断时间序列分析。
- 纳入179例接受AIS手术的患者,平均年龄15.4岁(范围11-30岁),女性159例、男性20例。
- GTMS引入前(2010年1月22日至2015年1月21日)63例,引入后(2015年1月22日至2020年1月22日)116例。
- 采用分段线性回归模型的中断时间序列分析评估GTMS对失血量的影响。
主要发现
- GTMS引入后使用率为40%。
- 术中失血量变化为-340 mL(95%CI:-649至-31,P=0.03)。
- 术后24小时引流量变化为-35 mL(95%CI:-124至55,P=0.44)。
- 总失血量变化为-375 mL(95%CI:-698至-51,P=0.02)。
关键数值与推荐
- 主要结局为术中失血量、术后24小时引流量和总失血量(术中失血量+术后24小时引流量)。
- 证据等级为3级。
临床怎么用
- 作者推荐在AIS手术中按需使用GTMS以控制术中出血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective cohort study with interrupted time series analysis. OBJECTIVE: To examine the clinical effectiveness of gelatin-thrombin matrix sealant (GTMS) on blood loss reduction after adolescent idiopathic scoliosis (AIS) surgery. SUMMARY OF BACKGROUND DATA: The real-world effectiveness of GTMS on blood loss reduction in AIS surgery has not been determined. PATIENTS AND METHODS: The medical records of patients receiving AIS surgery were retrospectively collected during a period before GTMS approval at our institution (January 22, 2010-January 21, 2015) as well as during a postintroduction period (January 22, 2015-January 22, 2020). The primary outcomes were intraoperative blood loss, drain output over 24 hours, and total blood loss (intraoperative blood loss + drain output over 24 h). Interrupted time series analysis using a segmented linear regression model was used to estimate the effect of GTMS on blood loss reduction. RESULTS: A total of 179 AIS patients [mean age (range): 15.4 (11-30) yr; 159 females and 20 males; 63 preintroduction patients and 116 postintroduction patients] were included. After its introduction, GTMS was used in 40% of cases. Interrupted time series analysis revealed changes of -340 mL (95% CI: -649 to -31, P = 0.03) for intraoperative blood loss, -35 mL (95% CI: -124 to 55, P = 0.44) for drain output over 24 hours, and -375 mL (95% CI: -698 to -51, P = 0.02) for total blood loss. CONCLUSIONS: The availability of GTMS was significantly associated with reduced intraoperative and total blood loss in AIS surgery. GTMS use as needed is recommended to control intraoperative bleeding in the setting of AIS surgery. LEVEL OF EVIDENCE: 3.
引用
- Mimura T, Ikegami S, Uehara M, et al. Real-World Effectiveness of Gelatin-Thrombin Matrix Sealant on Blood Loss in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion: An Interrupted Time Series Study. Spine (Phila Pa 1976). 2023. PMID: 37014827. doi:10.1097/BRS.0000000000004666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。